{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:27:21Z","timestamp":1793899641969,"version":"4.8.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T00:00:00Z","timestamp":1551225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.biopha.2019.108749","type":"journal-article","created":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T09:41:01Z","timestamp":1557308461000},"page":"108749","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Decrease of MLK4 prevents hepatocellular carcinoma (HCC) through reducing metastasis and inducing apoptosis regulated by ROS\/MAPKs signaling"],"prefix":"10.1016","volume":"116","author":[{"given":"Yu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anxiang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10064","key":"10.1016\/j.biopha.2019.108749_bib0005","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(16)32453-9","article-title":"Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"389","author":"Bruix","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2019.108749_bib0010","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.redox.2017.03.006","article-title":"Butyrate induces ROS-mediated apoptosis by modulating miR-22\/SIRT-1 pathway in hepatic cancer cells","volume":"12","author":"Pant","year":"2017","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2019.108749_bib0015","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.redox.2017.05.016","article-title":"Decoding NADPH oxidase 4 expression in human tumors","volume":"13","author":"Meitzler","year":"2017","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2019.108749_bib0020","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.redox.2017.01.012","article-title":"Metabolic zonation of the liver: the oxygen gradient revisited","volume":"11","author":"Kietzmann","year":"2017","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.biopha.2019.108749_bib0025","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/cmi.2011.15","article-title":"MLK4 has negative effect on TLR4 signaling","volume":"9","author":"Seit-Nebi","year":"2012","journal-title":"Cell. Mol. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2019.108749_bib0030","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.dld.2005.10.012","article-title":"Kinase domain mutation of MLK4 gene is uncommon in gastric and hepatocellular carcinomas","volume":"38","author":"Soung","year":"2006","journal-title":"Dig. Liver Dis."},{"issue":"6","key":"10.1016\/j.biopha.2019.108749_bib0035","doi-asserted-by":"crossref","first-page":"S1033","DOI":"10.21037\/tcr.2016.11.46","article-title":"MLK4 activates the NF-\u03baB network to drive mesenchymal transition in glioblastoma","volume":"5","author":"Quinn","year":"2016","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.biopha.2019.108749_bib0040","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1038\/ncomms4901","article-title":"Mixed lineage kinases activate MEK independently of RAF to mediate resistance to RAF inhibitors","volume":"5","author":"Marusiak","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2019.108749_bib0045","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-12-3074","article-title":"Mixed lineage kinase MLK4 is activated in colorectal cancers where it synergistically cooperates with activated RAS signaling in driving tumorigenesis","author":"Martini","year":"2013","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.biopha.2019.108749_bib0050","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ccell.2016.01.005","article-title":"Serine\/threonine kinase MLK4 determines mesenchymal identity in glioma stem cells in an NF-\u03baB-dependent manner","volume":"29","author":"Kim","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biopha.2019.108749_bib0055","doi-asserted-by":"crossref","first-page":"S591","DOI":"10.1016\/S0167-8140(18)31363-X","article-title":"PO-1053: a new radiation-inducible oncoprotein MLK4 and its role in in mediating breast cancer invasiveness","volume":"127","author":"Hong","year":"2018","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.biopha.2019.108749_bib0060","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.cbi.2015.12.011","article-title":"Naringin suppresses cell metastasis and the expression of matrix metalloproteinases (MMP-2 and MMP-9) via the inhibition of ERK-P38-JNK signaling pathway in human glioblastoma","volume":"244","author":"Aroui","year":"2016","journal-title":"Chem. Biol. Interact."},{"issue":"21","key":"10.1016\/j.biopha.2019.108749_bib0065","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1016\/j.biomaterials.2011.03.048","article-title":"The protective role of arjunolic acid against doxorubicin induced intracellular ROS dependent JNK-p38 and p53-mediated cardiac apoptosis","volume":"32","author":"Ghosh","year":"2011","journal-title":"Biomaterials"},{"issue":"18","key":"10.1016\/j.biopha.2019.108749_bib0070","doi-asserted-by":"crossref","first-page":"4995","DOI":"10.1016\/j.biomaterials.2010.02.068","article-title":"Multifunctional doxorubicin loaded superparamagnetic iron oxide nanoparticles for chemotherapy and magnetic resonance imaging in liver cancer","volume":"31","author":"Maeng","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2019.108749_bib0075","first-page":"257","article-title":"Codelivery of doxorubicin and curcumin with lipid nanoparticles results in improved efficacy of chemotherapy in liver cancer","volume":"10","author":"Zhao","year":"2015","journal-title":"Int. J. Nanomed."},{"issue":"5","key":"10.1016\/j.biopha.2019.108749_bib0080","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.3892\/or.2013.2338","article-title":"miR-101 inhibits autophagy and enhances cisplatin-induced apoptosis in hepatocellular carcinoma cells","volume":"29","author":"Xu","year":"2013","journal-title":"Oncol. Rep."},{"issue":"2","key":"10.1016\/j.biopha.2019.108749_bib0085","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.intimp.2014.05.026","article-title":"Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2\/-9 expression via AKT\/mTOR and ROS\/ERK1\/2 pathways","volume":"21","author":"Chen","year":"2014","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2019.108749_bib0090","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3109\/10799893.2012.695798","article-title":"PTEN regulation of ERK1\/2 signaling in cancer","volume":"32","author":"Chetram","year":"2012","journal-title":"J. Recept. Signal Transduct."},{"issue":"9","key":"10.1016\/j.biopha.2019.108749_bib0095","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nrm906","article-title":"Signalling: mixed-lineage kinase control of JNK and p38 MAPK pathways","volume":"3","author":"Gallo","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2019.108749_bib0100","doi-asserted-by":"crossref","DOI":"10.4137\/GEI.S6092","article-title":"Cloning and initial functional characterization of Mlk4\u03b1 and Mlk4\u03b2","volume":"4","author":"Kashuba","year":"2011","journal-title":"Genomics Insights"},{"key":"10.1016\/j.biopha.2019.108749_bib0105","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.CHTME14-B72","article-title":"Abstract B72: Serine\/threonine kinase MLK4 is a master regulator for proneural-mesenchymal transformation of glioma stem cells","author":"Sunghak","year":"2015","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.biopha.2019.108749_bib0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148408","article-title":"Galectin-1-induced autophagy facilitates cisplatin resistance of hepatocellular carcinoma","volume":"11","author":"Su","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.biopha.2019.108749_bib0115","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/hep.26369","article-title":"MicroRNA\u2010216a\/217\u2010induced epithelial\u2010mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer","volume":"58","author":"Xia","year":"2013","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.biopha.2019.108749_bib0120","first-page":"38","article-title":"Mutational analysis of caspase-7 and 8 genes in non-small cell lung cancer","volume":"4","author":"Soung","year":"2005","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.biopha.2019.108749_bib0125","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.freeradbiomed.2018.10.431","article-title":"Resveratrol protects photoreceptors by blocking caspase-and PARP-dependent cell death pathways","volume":"129","author":"Liu","year":"2018","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.biopha.2019.108749_bib0130","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrc2620","article-title":"Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits","volume":"9","author":"Polyak","year":"2009","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.biopha.2019.108749_bib0135","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/ncb1722","article-title":"The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1","volume":"10","author":"Gregory","year":"2008","journal-title":"Nat. Cell Biol."},{"issue":"7579","key":"10.1016\/j.biopha.2019.108749_bib0140","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nature16064","article-title":"Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer","volume":"527","author":"Zheng","year":"2015","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biopha.2019.108749_bib0145","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40169-015-0048-3","article-title":"EMT and tumor metastasis","volume":"4","author":"Heerboth","year":"2015","journal-title":"Clin. Transl. Med."},{"issue":"1","key":"10.1016\/j.biopha.2019.108749_bib0150","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/cdd.2016.95","article-title":"The degradation of EZH2 mediated by lncRNA ANCR attenuated the invasion and metastasis of breast cancer","volume":"24","author":"Li","year":"2017","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.biopha.2019.108749_bib0155","doi-asserted-by":"crossref","first-page":"15972","DOI":"10.1038\/srep15972","article-title":"Long non coding RNA MALAT1 promotes tumor growth and metastasis by inducing epithelial-mesenchymal transition in oral squamous cell carcinoma","volume":"5","author":"Zhou","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2019.108749_bib0160","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-12-4521","article-title":"Co-evolution of solid stress and interstitial fluid pressure in tumors during progression: implications for vascular collapse","author":"Stylianopoulos","year":"2013","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.biopha.2019.108749_bib0165","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nrc3803","article-title":"Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles\u2019 heel?","volume":"14","author":"Sabharwal","year":"2014","journal-title":"Nat. Rev. Cancer"},{"issue":"7260","key":"10.1016\/j.biopha.2019.108749_bib0170","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nature08268","article-title":"Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment","volume":"461","author":"Schafer","year":"2009","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.biopha.2019.108749_bib0175","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.cmet.2015.07.008","article-title":"Reversal of mitochondrial transhydrogenase causes oxidative stress in heart failure","volume":"22","author":"Nickel","year":"2015","journal-title":"Cell Metab."},{"issue":"8","key":"10.1016\/j.biopha.2019.108749_bib0180","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1158\/0008-5472.CAN-17-3155","article-title":"ME1 regulates NADPH homeostasis to promote gastric Cancer growth and metastasis","volume":"78","author":"Lu","year":"2018","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.biopha.2019.108749_bib0185","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1600-0609.2009.01387.x","article-title":"BCR-ABL-independent and RAS\/MAPK pathway-dependent form of imatinib resistance in Ph-positive acute lymphoblastic leukemia cell line with activation of EphB4","volume":"84","author":"Suzuki","year":"2010","journal-title":"Eur. J. Haematol."},{"issue":"1","key":"10.1016\/j.biopha.2019.108749_bib0190","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1186\/1471-2407-8-375","article-title":"Increased p38-MAPK is responsible for chemotherapy resistance in human gastric cancer cells","volume":"8","author":"Guo","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1016\/j.biopha.2019.108749_bib0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.freeradbiomed.2019.01.039","article-title":"Critical role of H2O2 in mediating sanguinarine-induced apoptosis in prostate cancer cells via facilitating ceramide generation, ERK1\/2 phosphorylation, and Par-4 cleavage","author":"Rahman","year":"2019","journal-title":"Free Radic. Biol. Med."},{"issue":"3","key":"10.1016\/j.biopha.2019.108749_bib0200","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/embo-reports\/kve046","article-title":"ASK1 is required for sustained activations of JNK\/p38 MAP kinases and apoptosis","volume":"2","author":"Tobiume","year":"2001","journal-title":"EMBO Rep."},{"issue":"2","key":"10.1016\/j.biopha.2019.108749_bib0205","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.canlet.2013.11.019","article-title":"p38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents","volume":"344","author":"Sui","year":"2014","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.biopha.2019.108749_bib0210","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12964-017-0179-9","article-title":"LASP2 suppresses colorectal cancer progression through JNK\/p38 MAPK pathway meditated epithelial-mesenchymal transition","volume":"15","author":"Wang","year":"2017","journal-title":"Cell Commun. Signal."},{"issue":"4","key":"10.1016\/j.biopha.2019.108749_bib0215","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.bbrc.2017.04.133","article-title":"Brusatol inhibits growth and induces apoptosis in pancreatic cancer cells via JNK\/p38 MAPK\/NF-\u03bab\/Stat3\/Bcl-2 signaling pathway","volume":"487","author":"Xiang","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.biopha.2019.108749_bib0220","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1023\/A:1023781114568","article-title":"Role of MAP kinase in tumor progression and invasion","volume":"22","author":"Reddy","year":"2003","journal-title":"Cancer Metastasis Rev."},{"issue":"1","key":"10.1016\/j.biopha.2019.108749_bib0225","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-2407-12-26","article-title":"TGF-\u03b21 modulates the homeostasis between MMPs and MMP inhibitors through p38 MAPK and ERK1\/2 in highly invasive breast cancer cells","volume":"12","author":"Gomes","year":"2012","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2019.108749_bib0230","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/cmi.2011.15","article-title":"MLK4 has negative effect on TLR4 signaling","volume":"9","author":"Seit-Nebi","year":"2012","journal-title":"Cell. Mol. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2019.108749_bib0235","first-page":"3317","article-title":"Mixed lineage kinase-4 promotes gastric carcinoma tumorigenesis through suppression of the c-Jun N-terminal kinase signaling pathway","volume":"16","author":"Xi","year":"2018","journal-title":"Exp. Ther. Med."}],"updated-by":[{"DOI":"10.1016\/j.biopha.2020.109815","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000}}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332219301969?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332219301969?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T16:53:53Z","timestamp":1793897633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332219301969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":47,"alternative-id":["S0753332219301969"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2019.108749","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decrease of MLK4 prevents hepatocellular carcinoma (HCC) through reducing metastasis and inducing apoptosis regulated by ROS\/MAPKs signaling","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2019.108749","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"108749"}}